These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32143721)

  • 41. Safety and efficacy of misoprostol versus oxytocin for the prevention of postpartum hemorrhage.
    Rajaei M; Karimi S; Shahboodaghi Z; Mahboobi H; Khorgoei T; Rajaei F
    J Pregnancy; 2014; 2014():713879. PubMed ID: 24734184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage.
    Fawole AO; Sotiloye OS; Hunyinbo KI; Umezulike AC; Okunlola MA; Adekanle DA; Osamor J; Adeyanju O; Olowookere OO; Adekunle AO; Singata M; Mangesi L; Hofmeyr GJ
    Int J Gynaecol Obstet; 2011 Feb; 112(2):107-11. PubMed ID: 21130446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic tranexamic acid in Cesarean delivery: an updated meta-analysis with a trial sequential analysis.
    Provinciatto H; Barbalho ME; da Câmara PM; Donadon IB; Fonseca LM; Bertani MS; Marinho AD; Sirena E; Provinciatto A; Amaral S
    Can J Anaesth; 2024 Apr; 71(4):465-478. PubMed ID: 38453797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali.
    Dumont A; Bodin C; Hounkpatin B; Popowski T; Traoré M; Perrin R; Rozenberg P
    BMJ Open; 2017 Sep; 7(9):e016590. PubMed ID: 28864699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Misoprostol and oxytocin versus oxytocin alone in the active management of the third stage of labour: a randomised, double-blind, placebo-controlled trial.
    Ottun TA; Adewunmi AA; Rabiu AK; Olumodeji AM; Oladipo OM; Olalere HF
    J Obstet Gynaecol; 2022 Jul; 42(5):1048-1053. PubMed ID: 34958620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P; Biswas J; Mandal A
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet.
    Miller S; Tudor C; Thorsten V; Nyima ; Kalyang ; Sonam ; Lhakpen ; Droyoung ; Quzong K; Dekyi T; Hartwell T; Wright LL; Varner MW
    J Midwifery Womens Health; 2009; 54(2):133-141.e1. PubMed ID: 19249659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Misoprostol for the prevention and treatment of postpartum hemorrhage.
    Sheldon WR; Blum J; Durocher J; Winikoff B
    Expert Opin Investig Drugs; 2012 Feb; 21(2):235-50. PubMed ID: 22233426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
    Hashima-E-Nasreen ; Nahar S; Al Mamun M; Afsana K; Byass P
    Glob Health Action; 2011; 4():. PubMed ID: 21845143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.
    Simonazzi G; Bisulli M; Saccone G; Moro E; Marshall A; Berghella V
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):28-37. PubMed ID: 26698831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness and budget impact of adding tranexamic acid for management of post-partum hemorrhage in the Indian public health system.
    Joshi BN; Shetty SS; Moray KV; Chaurasia H; Sachin O
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):9. PubMed ID: 36609241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tranexamic acid for the prevention of blood loss after cesarean among women with twins: a secondary analysis of the TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery randomized clinical trial.
    Sentilhes L; Madar H; Le Lous M; Sénat MV; Winer N; Rozenberg P; Kayem G; Verspyck E; Fuchs F; Azria E; Gallot D; Korb D; Desbrière R; Le Ray C; Chauleur C; de Marcillac F; Perrotin F; Parant O; Salomon LJ; Gauchotte E; Bretelle F; Sananès N; Bohec C; Mottet N; Legendre G; Letouzey V; Haddad B; Vardon D; Mattuizzi A; Froeliger A; Bouchghoul H; Daniel V; Regueme S; Roussillon C; Georget A; Darsonval A; Benard A; Deneux-Tharaux C;
    Am J Obstet Gynecol; 2022 Dec; 227(6):889.e1-889.e17. PubMed ID: 35724759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the efficacy of prophylactic tranexamic acid in preventing postpartum bleeding: systematic review with meta-analysis of randomized clinical trials.
    Assis IC; Govêia CS; Miranda DB; Ferreira RS; Riccio LGC
    Braz J Anesthesiol; 2023; 73(4):467-476. PubMed ID: 35995323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using misoprostol to treat postpartum hemorrhage in home deliveries attended by traditional birth attendants.
    Abbas DF; Jehan N; Diop A; Durocher J; Byrne ME; Zuberi N; Ahmed Z; Walraven G; Winikoff B
    Int J Gynaecol Obstet; 2019 Mar; 144(3):290-296. PubMed ID: 30582753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tranexamic acid, as an adjunct to oxytocin prophylaxis, in the prevention of postpartum haemorrhage in women undergoing elective caesarean section: A single-centre double-blind randomised controlled trial.
    Lee SH; Kwek ME; Tagore S; Wright A; Ku CW; Teong ACA; Tan AWM; Lim SWC; Yen DYT; Ang CYX; Sultana R; Lim CHF; Mathur D; Mathur M
    BJOG; 2023 Aug; 130(9):1007-1015. PubMed ID: 36852501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment for primary postpartum haemorrhage.
    Mousa HA; Alfirevic Z
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003249. PubMed ID: 17253486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Misoprostol: off-label use in the treatment of post-partum hemorrhage].
    Garrigue A; Pierre F
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):179-89. PubMed ID: 24457021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.
    Badejoko OO; Ijarotimi AO; Awowole IO; Loto OM; Badejoko BO; Olaiya DS; Fatusi AO; Kuti O; Orji EO; Ogunniyi SO
    J Obstet Gynaecol Res; 2012 Nov; 38(11):1294-301. PubMed ID: 22612662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating tranexamic acid for the prevention and treatment of obstetric hemorrhage.
    Kowalczyk JJ; Cecconi M; Butwick AJ
    Curr Opin Obstet Gynecol; 2024 Apr; 36(2):88-96. PubMed ID: 38170626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.